Michel Lagarde - Dec 4, 2025 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Executive Vice President & COO
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Michel Lagarde
Stock symbol
TMO
Transactions as of
Dec 4, 2025
Transactions value $
-$7,539,568
Form type
4
Date filed
12/5/2025, 04:40 PM
Previous filing
Dec 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lagarde Michel Executive Vice President & COO 168 THIRD AVENUE, WALTHAM /s/ Melodie T. Morin, Attorney-in-Fact for Michel Lagarde 2025-12-05 0001518973

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Options Exercise $1.96M +18.6K +28.46% $105.17 84.1K Dec 4, 2025 Direct
transaction TMO Common Stock Options Exercise $2.92M +22K +26.21% $132.66 106K Dec 4, 2025 Direct
transaction TMO Common Stock Sale -$12.4M -22K -20.77% $563.56 84.1K Dec 4, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -22K -100% $0.00 0 Dec 4, 2025 Common Stock 22K $132.66 Direct F2
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -18.6K -100% $0.00 0 Dec 4, 2025 Common Stock 18.6K $105.17 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $563.38 to $564.20, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The option vested in three equal installments on March 23, 2018, 2019 and 2020.
F3 The option vested in two equal installments on August 29, 2017 and 2020.